CSI Market
Sign In | Register

Nervgen Pharma (NGEN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NGEN Annual Balance Sheets →
This balance sheet overview for Nervgen Pharma spans from Dec 31 2024 to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents16.10
Cash & Short-term Investments16.00
Trade & Other Current Receivables (IFRS combined total)0.06
Other Current Assets0.56
Total Current Assets16.63
Intangible Assets0.30
Tax Assets, Noncurrent19.96
Other Assets, Noncurrent0.31
Total Assets16.93
Liabilities
Accounts Payable3.40
Other Liabilities, Current15.12
Total Current Liabilities14.39
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities14.39
Stockholders' Equity
Other Equity2.66
Common Stockholder's Equity2.66
Total Stockholder's Equity2.54
Liabilities & Stockholder's Equity16.93
4 historic quarters locked

Sign in to unlock the full Nervgen Pharma balance sheet history.

Sign In Create Free Account

About Nervgen Pharma Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 40-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-037357

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License